is a 5-year agreement from
1 July 2020-30 June 2025
compared to the estimated 6CPA outcome
of $16.8 billion
Increased investment in programs to increase access to PBS medicines for Aboriginal and Torres Strait Islander peoples through the Closing the Gap PBS Co-payment measure and the provision of uncapped access to Dose Administration Aids.
Electronic Prescription Fees continue to be paid through approved pharmacists for the first year, after which payments will be made directly to Prescription Exchange Service providers.